Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
JanOne – Smallcap über Nacht mit Milliardentransaktionen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
105 Leser
Artikel bewerten:
(0)

Tecan Group AG: Tecan schedules Analyst and Media Conference on March 18 to discuss Full-Year 2014 Financial Results

Tecan Group AG / Tecan schedules Analyst and Media Conference on March 18 to discuss Full-Year 2014 Financial Results . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Männedorf, Switzerland, March 11, 2015 - The Tecan Group AG (SIX Swiss Exchange: TECN) will hold an Analyst and Media Conference to discuss the full-year 2014 financial results on Wednesday, March 18, 2015 at 09:30 CET in Zurich. The results will be published on March 18, 2015 at 6:30 CET.

The conference will be audio-webcast with synchronized presentation slides. Interested parties may access the webcast via Tecan's homepage www.tecan.com (http://www.tecan.com/). A link to the webcast will be provided immediately prior to the event.

Interested parties can also listen to the conference by phone.
The dial-in numbers for the call are as follows:
Participants from Europe: +41 58 310 5000 or +44 203 059 58 62 (UK)
Participants from the U.S.: +1 631 570 5613

Participants should if possible dial in 15 minutes before the start of the event.

The recorded webcast will be available the same day on the website www.tecan.com together with the press release, the presentation and a preprint of the Financial Report 2014. An iPad app for Financial Reports of the Tecan Group is also available from the App Store.

About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions
in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2013, Tecan generated sales of CHF 388 million (USD 419 million; EUR 316 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

For further information:

Tecan Group
Martin Braendle
VP, Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com (http://www.tecan.com/)

Press Release (http://hugin.info/100384/R/1901203/675917.pdf)



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Tecan Group AG via Globenewswire

HUG#1901203

--- End of Message ---

Tecan Group AG
Seestrasse 103 Maennedorf Switzerland

ISIN: CH0012100191;


Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2015 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.